Citations (465)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (53)
Geir Hetland, Magne Kristoffer Fagerhol, Veselka Petrova Dimova-Svetoslavova, Mohammad Reza Mirlashari, Nhan Trung Nguyen, Andreas Lind, Svein Olav Kolset, Arne Vasli Lund Søraas & Lise Sofie Haug Nissen-Meyer. (2022) Inflammatory markers calprotectin, NETs, syndecan-1 and neopterin in COVID-19 convalescent blood donors. Scandinavian Journal of Clinical and Laboratory Investigation 82:6, pages 481-485.
Read now
Read now
Changchang Ge, Yi Lu, Hong Shen & Lei Zhu. (2022) Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitis. Scandinavian Journal of Gastroenterology 57:5, pages 513-524.
Read now
Read now
Yunling Wen, Junkun Niu, Fengrui Zhang, Jing Wu, Maojuan Li, Yang Sun, Wen Wang, Shuxian Xia, Ying Tan, Kunhua Wang & Yinglei Miao. (2020) Heat shock transcription factor 2 predicts mucosal healing and promotes mucosal repair of ulcerative colitis. Scandinavian Journal of Gastroenterology 55:6, pages 677-686.
Read now
Read now
C.-G. Af Björkesten, A. Jussila, H. Kemppainen, T. Hallinen, E. Soini, P. Mankinen, S. Valgarðsson, V. Veckman, R. Nissinen, D. Naessens & P. Molander. (2019) Relationship of faecal calprotectin and long-term outcomes in Finnish patients with Crohn’s disease: retrospective multi-centre chart review study. Scandinavian Journal of Gastroenterology 54:10, pages 1226-1232.
Read now
Read now
Amanda Ricciuto & Anne M. Griffiths. (2019) Clinical value of fecal calprotectin. Critical Reviews in Clinical Laboratory Sciences 56:5, pages 307-320.
Read now
Read now
Pontus Karling, David Lundgren, Vincy Eklöf, Richard Palmqvist & Johan Hultdin. (2019) Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectin. Scandinavian Journal of Clinical and Laboratory Investigation 79:5, pages 341-346.
Read now
Read now
Christopher Ma, Robert Battat, Claire E. Parker, Reena Khanna, Vipul Jairath & Brian Gordon Feagan. (2019) Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn’s disease?. Expert Review of Gastroenterology & Hepatology 13:4, pages 319-330.
Read now
Read now
Hu Zhang, Zhen Zeng, Arjudeb Mukherjee & Bo Shen. (2018) Molecular diagnosis and classification of inflammatory bowel disease. Expert Review of Molecular Diagnostics 18:10, pages 867-886.
Read now
Read now
Cong Dai, Min Jiang & Ming-Jun Sun. (2018) Fecal markers in the management of inflammatory bowel disease. Postgraduate Medicine 130:7, pages 597-606.
Read now
Read now
RD Østgård, BW Deleuran, MY Dam, IT Hansen, AG Jurik & H Glerup. (2018) Faecal calprotectin detects subclinical bowel inflammation and may predict treatment response in spondyloarthritis. Scandinavian Journal of Rheumatology 47:1, pages 48-55.
Read now
Read now
Takayuki Yamamoto & Takahiro Shimoyama. (2017) Monitoring and detection of disease recurrence after resection for Crohn’s disease: the role of non-invasive fecal biomarkers. Expert Review of Gastroenterology & Hepatology 11:10, pages 899-909.
Read now
Read now
Andrew S. Day, Steven T. Leach & Daniel A. Lemberg. (2017) An update on diagnostic and prognostic biomarkers in inflammatory bowel disease. Expert Review of Molecular Diagnostics 17:9, pages 835-843.
Read now
Read now
Lukasz Kwapisz, Jamie Gregor, Nilesh Chande, Brian Yan, Terry Ponich & Mahmoud Mosli. (2017) The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 52:8, pages 846-850.
Read now
Read now
Ping Jin, Kui Wang, Canhua Huang & Edouard C. Nice. (2017) Mining the fecal proteome: from biomarkers to personalised medicine. Expert Review of Proteomics 14:5, pages 445-459.
Read now
Read now
Paula Ministro & Diana Martins. (2017) Fecal biomarkers in inflammatory bowel disease: how, when and why?. Expert Review of Gastroenterology & Hepatology 11:4, pages 317-328.
Read now
Read now
Karin Amcoff, Mats Stridsberg, Maria Lampinen, Anders Magnuson, Marie Carlson & Jonas Halfvarson. (2017) Clinical implications of assay specific differences in f-calprotectin when monitoring inflammatory bowel disease activity over time. Scandinavian Journal of Gastroenterology 52:3, pages 344-350.
Read now
Read now
Daniel Muthas, Anna Reznichenko, Clare A. Balendran, Gerhard Böttcher, Ib Groth Clausen, Carina Kärrman Mårdh, Tomas Ottosson, Mohib Uddin, Thomas T. MacDonald, Silvio Danese & Mark Berner Hansen. (2017) Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications. Scandinavian Journal of Gastroenterology 52:2, pages 125-135.
Read now
Read now
Cecilia Högberg, Pontus Karling, Jörgen Rutegård & Mikael Lilja. (2017) Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study. Scandinavian Journal of Gastroenterology 52:1, pages 69-75.
Read now
Read now
Natalie E Walsham & Roy A Sherwood. (2016) Fecal calprotectin in inflammatory bowel disease. Clinical and Experimental Gastroenterology 9, pages 21-29.
Read now
Read now
Magali de Bruyn, Jennifer Vandooren, Estefania Ugarte-Berzal, Ingrid Arijs, Séverine Vermeire & Ghislain Opdenakker. (2016) The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases. Critical Reviews in Biochemistry and Molecular Biology 51:5, pages 295-358.
Read now
Read now
Rocio Ferreiro-Iglesias, Manuel Barreiro-de Acosta, Aurelio Lorenzo-Gonzalez & Juan Enrique Dominguez-Muñoz. (2016) Usefulness of a rapid faecal calprotectin test to predict relapse in Crohn’s disease patients on maintenance treatment with adalimumab. Scandinavian Journal of Gastroenterology 51:4, pages 442-447.
Read now
Read now
Vendel Kristensen, Trine Lauritzen, Lars-Petter Jelsness-JØrgensen & BjØrn Moum. (2015) Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods. Scandinavian Journal of Clinical and Laboratory Investigation 75:5, pages 355-361.
Read now
Read now
Morten H. Vatn & Arne K. Sandvik. (2015) Inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:6, pages 748-762.
Read now
Read now
Taina Sipponen & Kaija-Leena Kolho. (2015) Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:1, pages 74-80.
Read now
Read now
Tonje Oord & Nete Hornung. (2014) Fecal calprotectin in healthy children. Scandinavian Journal of Clinical and Laboratory Investigation 74:3, pages 254-258.
Read now
Read now
Emanuel Burri & Christoph Beglinger. (2014) The use of fecal calprotectin as a biomarker in gastrointestinal disease. Expert Review of Gastroenterology & Hepatology 8:2, pages 197-210.
Read now
Read now
Polychronis Pavlidis, Fergus JQ Chedgy & Jeremy A Tibble. (2013) Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care. Scandinavian Journal of Gastroenterology 48:9, pages 1048-1054.
Read now
Read now
Hans Linde Nielsen, Jørgen Engberg, Tove Ejlertsen & Henrik Nielsen. (2013) Evaluation of fecal calprotectin in Campylobacter concisus and Campylobacter jejuni/coli gastroenteritis. Scandinavian Journal of Gastroenterology 48:5, pages 633-635.
Read now
Read now
Michael Dam Jensen, Jens Kjeldsen & Torben Nathan. (2011) Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon. Scandinavian Journal of Gastroenterology 46:6, pages 694-700.
Read now
Read now
Maria H. Lönnkvist, Elvar Theodorsson, Mikael Holst, Tryggve Ljung & Per M. Hellström. (2011) Blood chemistry markers for evaluation of inflammatory activity in Crohn's disease during infliximab therapy. Scandinavian Journal of Gastroenterology 46:4, pages 420-427.
Read now
Read now
Taina Sipponen & Kaija-Leena Kolho. (2010) Faecal calprotectin in children with clinically quiescent inflammatory bowel disease. Scandinavian Journal of Gastroenterology 45:7-8, pages 872-877.
Read now
Read now
Taina Sipponen, Clas-Göran AF Björkesten, Martti Färkkilä, Hannu Nuutinen, Erkki Savilahti & Kaija-Leena Kolho. (2010) Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment. Scandinavian Journal of Gastroenterology 45:3, pages 325-331.
Read now
Read now
T. A. Vestergaard, S. L. Nielsen, J. F. Dahlerup & N. Hornung. (2008) Fecal calprotectin: assessment of a rapid test. Scandinavian Journal of Clinical and Laboratory Investigation 68:4, pages 343-347.
Read now
Read now
Jun Dai, Wen-Zhong Liu, Yong-Ping Zhao, Yun-Biao Hu & Zhi-Zheng Ge. (2007) Relationship between fecal lactoferrin and inflammatory bowel disease. Scandinavian Journal of Gastroenterology 42:12, pages 1440-1444.
Read now
Read now
Claudia I. Reinders, Daisy Jonkers, Emmelie Å. Jansson, Reinhold W. Stockbrügger, Ellen E. Stobberingh, Per M. Hellström & Jon O. Lundberg. (2007) Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 42:10, pages 1151-1157.
Read now
Read now
Steven T Leach & Andrew S Day. (2006) S100 proteins in the pathogenesis and diagnosis of inflammatory bowel disease. Expert Review of Clinical Immunology 2:3, pages 471-480.
Read now
Read now
Njaal Stray & Ragnar Weberg. (2006) A prospective study of same day bi-directional endoscopy in the evaluation of patients with occult gastrointestinal bleeding. Scandinavian Journal of Gastroenterology 41:7, pages 844-850.
Read now
Read now
M. K. Fagerhol, H. G. Nielsen, A. Vetlesen, K. Sandvik & T. Lyberg. (2005) Increase in plasma calprotectin during long‐distance running. Scandinavian Journal of Clinical and Laboratory Investigation 65:3, pages 211-220.
Read now
Read now
K. O. Laake, P. D. Line, K. Grzyb, G. Aamodt, L. Aabakken, A. Røset, A. B. Hvinden, A. Bakka, J. Eide, A. Bjørneklett & M. H. Vatn. (2004) Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-Configurated ileal-pouch-anal-anastomosis (IPAA). Scandinavian Journal of Gastroenterology 39:12, pages 1228-1235.
Read now
Read now
A. G. Røseth, E. Aadland & K. Grzyb. (2004) Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 39:10, pages 1017-1020.
Read now
Read now
A. Larsen, N. Hovdenak, Á. Karlsdottir, T. Wentzel-Larsen, O. Dahl & M. K. Fagerhol. (2004) Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: a pilot study of eight stool markers. Scandinavian Journal of Gastroenterology 39:11, pages 1113-1118.
Read now
Read now
K. O. Laake, P. D. Line, L. Aabakken, T. Løtveit, A. Bakka, J. Eide, A. Røsetti, K. Grzyb, A. Bjørneklett & M. H. Vatn. (2003) Assessment of Mucosal Inflammation and Circulation in Response to Probiotics in Patients Operated with Ileal Pouch Anal Anastomosis for Ulcerative Colitis. Scandinavian Journal of Gastroenterology 38:4, pages 409-414.
Read now
Read now
B. Johne, O. Kronborg, H. I. Tøn, J. Kristinsson, P. Fuglerud. (2001) A New Fecal Calprotectin Test for Colorectal Neoplasia: Clinical Results and Comparison with Previous Method. Scandinavian Journal of Gastroenterology 36:3, pages 291-296.
Read now
Read now
A. Berstad, G. Arslan, G. Folvik. (2000) Relationship between Intestinal Permeability and Calprotectin Concentration in Gut Lavage Fluid. Scandinavian Journal of Gastroenterology 35:1, pages 64-69.
Read now
Read now
A. G. Røseth, P. N. Schmidt, M. K. Fagerhol. (1999) Correlation between Faecal Excretion of Indium-111-Labelled Granulocytes and Calprotectin, a Granulocyte Marker Protein, in Patients with Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 34:1, pages 50-54.
Read now
Read now
Kjell Saatvedt, Harald Lindberg, Odd Ragnar Geiran, Svein Michelsen, Thore Pedersen, Egil Seem & Magne Fagerhol. (1996) Release of Interleukin-8 and Calprotectin During and after Paediatric Cardiopulmonary Bypass with and Without Ultrafiltration. Scandinavian Journal of Thoracic and Cardiovascular Surgery 30:2, pages 53-59.
Read now
Read now
John A. Olson, Marianne Forrester, Paul A. Clohessy, Barbara E. Golden, Richard Herriot & John V. Forrester. (1996) Calprotectin is raised in endogenous posterior uveitis. Ocular Immunology and Inflammation 4:2, pages 91-98.
Read now
Read now
T. R. Meling, L. Aabakken, A. Røseth & M. Osnes. (1996) Faecal Calprotectin Shedding after Short-Term Treatment with Non-Steroidal Anti-Inflammatory Drugs. Scandinavian Journal of Gastroenterology 31:4, pages 339-344.
Read now
Read now
J. A. Gilbert, D. A. Ahlquist, D. W. Mahoney, A. R. Zinsmeister, J. Rubin & R. D. Ellefson. (1996) Fecal Marker Variability in Colorectal Cancer: Calprotectin versus Hemoglobin. Scandinavian Journal of Gastroenterology 31:10, pages 1001-1005.
Read now
Read now
J. Kjeldsen-Kragh, O. J. Mellbye, M. Haugen, T. E. Mollnes, H. B. Hammer, M. Sioud & Ø. Førre. (1995) Changes in Laboratory Variables in Rheumatoid Arthritis Patients During a Trial of Fasting and One-year Vegetarian Diet. Scandinavian Journal of Rheumatology 24:2, pages 85-93.
Read now
Read now
Marcela Pekna, Jan Borowiec, Magne K. Fagerhol, Per Venge & Stefan Thelin. (1994) Biocompatibility of Heparin-Coated Circuits Used in Cardiopulmonary Bypass. Scandinavian Journal of Thoracic and Cardiovascular Surgery 28:1, pages 5-11.
Read now
Read now
J. G. Brun, M. Cuida, H. Jacobsen, R. Kloster, A. C. Johannesen, H. M. Høyeraal & R. Jonsson. (1994) Sjögren's Syndrome in Inflammatory Rheumatic Diseases: Analysis of the Leukocyte Protein Calprotectin in Plasma and Saliva. Scandinavian Journal of Rheumatology 23:3, pages 114-118.
Read now
Read now
A. G. Røseth, J. Kristinsson, M. K. Fagerhol, H. Schjønsby, E. Aadland, K. Nygaard & B. Roald. (1993) Faecal Calprotectin: A Novel Test for the Diagnosis of Colorectal Cancer?. Scandinavian Journal of Gastroenterology 28:12, pages 1073-1076.
Read now
Read now
Articles from other publishers (412)
Elton Dajti, Leonardo Frazzoni, Veronica Iascone, Matteo Secco, Amanda Vestito, Lorenzo Fuccio, Leonardo Henry Eusebi, Pietro Fusaroli, Fernando Rizzello, Carlo Calabrese, Paolo Gionchetti, Franco Bazzoli & Rocco Maurizio Zagari. (2023) Systematic review with meta‐analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults. Alimentary Pharmacology & Therapeutics 58:11-12, pages 1120-1131.
Crossref
Crossref
A. A. Kamalova, G. A. Garina, I. Kh. Valeeva & A. R. Gaifutdinova. (2023) Fecal calprotectin as a marker of inflammatory bowel diseases. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 68:5, pages 138-143.
Crossref
Crossref
Margo B. Heston, Kendra L. Hanslik, Katie R. Zarbock, Sandra J. Harding, Nancy J. Davenport-Sis, Robert L. Kerby, Nathaniel Chin, Yi Sun, Ana Hoeft, Yuetiva Deming, Nicholas M. Vogt, Tobey J. Betthauser, Sterling C. Johnson, Sanjay Asthana, Gwendlyn Kollmorgen, Ivonne Suridjan, Norbert Wild, Henrik Zetterberg, Kaj Blennow, Federico E. Rey, Barbara B. Bendlin & Tyler K. Ulland. (2023) Gut inflammation associated with age and Alzheimer’s disease pathology: a human cohort study. Scientific Reports 13:1.
Crossref
Crossref
Naohiro Nakamura, Yusuke Honzawa, Shuhei Nishimon, Yasuki Sano, Yutaro Tokutomi, Yuka Ito, Naoto Yagi, Sanshiro Kobayashi, Mamiko Aoi, Tomomitsu Tahara, Norimasa Fukata, Toshiro Fukui & Makoto Naganuma. (2023) Combined serum albumin, fecal immunochemical test, and leucine-rich alpha-2 glycoprotein levels for predicting prognosis in remitting patients with ulcerative colitis. Scientific Reports 13:1.
Crossref
Crossref
Frank Wagner, John C Mansfield, Annemarie N Lekkerkerker, Yehong Wang, Mary Keir, Ajit Dash, Brandon Butcher, Brandon Harder, Luz D Orozco, Jordan S Mar, Hao Chen & Michael E Rothenberg. (2023) Dose escalation randomised study of efmarodocokin alfa in healthy volunteers and patients with ulcerative colitis. Gut 72:8, pages 1451-1461.
Crossref
Crossref
Jennifer Murray, Klaartje B Kok & Ruth M Ayling. (2023) Fecal Calprotectin in Gastrointestinal Disease. Clinical Chemistry 69:7, pages 699-710.
Crossref
Crossref
Helen Bruce, Jacqueline Osypiw, Geeta Prajapati-Jha, Shane O’Driscoll, Martin Brealey & Sally C Benton. (2023) Comparison of faecal calprotectin using two collection and extraction strategies for the BÜHLMANN CALEX® Cap – possible implications for clinical cut-offs?. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 60:4, pages 236-242.
Crossref
Crossref
Mari Kärki, Laura Tanner, Satu Lahtinen, Tero Soukka & Harri Niinikoski. (2023) Plasma calprotectin is extremely high in patients with lysinuric protein intolerance. JIMD Reports 64:4, pages 293-299.
Crossref
Crossref
Denise S. Riggers, Panagiotis G. Xenoulis, Dimitra A. Karra, Lena L. Enderle, Gabor Köller, Denny Böttcher, Joerg M. Steiner & Romy M. Heilmann. (2023) Fecal Calprotectin Concentrations in Cats with Chronic Enteropathies. Veterinary Sciences 10:7, pages 419.
Crossref
Crossref
Massimo Claudio Fantini, Erica Loddo, Amalia Di Petrillo & Sara Onali. (2023) Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review. Digestive and Liver Disease.
Crossref
Crossref
Lies E J L Dijkhuis, Femke Crouwel, Marjolijn Duijvestein, Hans J C Buiter, Nanne K de Boer & Henrike M Hamer. (2023) The Reliability of Patient-Performed Fecal Calprotectin Testing in Inflammatory Bowel Disease. The Journal of Applied Laboratory Medicine 8:2, pages 319-329.
Crossref
Crossref
Aurelio Seidita, Pasquale Mansueto, Alessandra Giuliano, Marta Chiavetta, Maurizio Soresi & Antonio Carroccio. (2023) Fecal Calprotectin in Self-Reported Milk Intolerance: Not Only Lactose Intolerance. Nutrients 15:4, pages 1048.
Crossref
Crossref
Nathan Hargreaves Noguera & Dyana Carla Lima. 2023. Natural Plant Products in Inflammatory Bowel Diseases. Natural Plant Products in Inflammatory Bowel Diseases
173
213
.
Barbara Niklinska-Schirtz & Cary G. Sauer. 2023. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
245
253
.
Amanda Wenzel, Benjamin D. Gold & Jennifer Strople. 2023. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
229
244
.
Akhilesh Swaminathan, Grace M Borichevsky, Teagan S Edwards, Esther Hirschfeld, Thomas C Mules, Chris M A Frampton, Andrew S Day, Mark B Hampton, Anthony J Kettle & Richard B Gearry. (2022) Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 16:12, pages 1862-1873.
Crossref
Crossref
Fiona A. Ross, James H. Park, David Mansouri, Emilie Combet, Paul G. Horgan, Donald C. McMillan & Campbell S. D. Roxburgh. (2022) The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis. BMC Gastroenterology 22:1.
Crossref
Crossref
Igor Soares, Bruna L. Belote, Elizabeth Santin, Gabriela C. Dal Pont & Michael H. Kogut. (2022) Morphological Assessment and Biomarkers of Low-Grade, Chronic Intestinal Inflammation in Production Animals. Animals 12:21, pages 3036.
Crossref
Crossref
Aditya ChilayDrDr, Neha MehraDrDr, Moumita MisraDrDr, Flavia Almeida, Kirti ChadhaDrDr, Raj Jatale & Shibani RamchandranDrDr. (2022) ROLE OF FECAL CALPROTECTIN FOR ASSESSMENT OF INFLAMMATORY BOWEL DISEASE ACTIVITY, 4-YEAR STUDY DONE IN INDIAN REFERENCE LABORATORY. INDIAN JOURNAL OF APPLIED RESEARCH, pages 33-35.
Crossref
Crossref
Polychronis Pavlidis, Deepak Joshi, Yasser El Sherif, Ben Warner, Shraddha Gulati, James Alexander, Gemma Cross, Tracy Dew, Hadil Abu Arqoub, John Devlin, Michael Heneghan, Patrick Dubois, Ingvar Bjarnason, Nick Powell & Bu'Hussain Hayee. (2022) Faecal calprotectin is a surrogate marker of biliary inflammation in primary sclerosing cholangitis associated inflammatory bowel disease. Frontline Gastroenterology 13:6, pages 497-502.
Crossref
Crossref
Henrike M Hamer, A H Leontine Mulder, Nanne K de Boer, Femke Crouwel, Patrick F van Rheenen, Marlies Spekle, Marloes Vermeer, Lucie Wagenmakers-Huizinga & Anneke C Muller Kobold. (2022) Impact of Preanalytical Factors on Calprotectin Concentration in Stool: A Multiassay Comparison. The Journal of Applied Laboratory Medicine 7:6, pages 1401-1411.
Crossref
Crossref
Juozas Butenas & Ruth M. Ayling. (2022) Clinical evaluation of the OC-Sensor Pledia calprotectin assay. Clinical Chemistry and Laboratory Medicine (CCLM) 60:11, pages 1780-1785.
Crossref
Crossref
Joachim Høg Mortensen, Dovile Sinkeviciute, Tina Manon-Jensen, Viktor Domislović, Kathryn McCall, Christian S Thudium, Marko Brinar, Patrik Önnerfjord, Carl S Goodyear, Željko Krznarić, Morten Asser Karsdal & Anne-Christine Bay-Jensen. (2022) A Specific Calprotectin Neo-epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity. Journal of Crohn's and Colitis 16:9, pages 1447-1460.
Crossref
Crossref
Lena L. Enderle, Gabor Köller & Romy M. Heilmann. (2022) Verification of the fCAL turbo immunoturbidimetric assay for measurement of the fecal calprotectin concentration in dogs and cats. Journal of Veterinary Diagnostic Investigation 34:5, pages 813-824.
Crossref
Crossref
Sonya S. Dasharathy, Berkeley N. Limketkai & Jenny S. Sauk. (2021) What’s New in the Postoperative Management of Crohn’s Disease?. Digestive Diseases and Sciences 67:8, pages 3508-3517.
Crossref
Crossref
Zahra Alghoul, Chunhua Yang & Didier Merlin. (2022) The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease. Biomedicines 10:7, pages 1492.
Crossref
Crossref
Pavel Frühauf. (2022) Fecal calprotectin. Pediatrie pro praxi 23:3, pages 243-244.
Crossref
Crossref
Qianyi Zheng, Yongkang Chen, Yanping Zhai, Lin Meng, Han Liu, Haiyan Tian, Renyi Feng, Jiuqi Wang, Rui Zhang, Kedi Sun, Lina Gao, Yijing Wang, Xuejing Wang, Erxi Wu, Junfang Teng & Xuebing Ding. (2022) Gut Dysbiosis Is Associated With the Severity of Cryptogenic Stroke and Enhanced Systemic Inflammatory Response. Frontiers in Immunology 13.
Crossref
Crossref
Nikolas Plevris & Charlie W. Lees. (2022) Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities. Gastroenterology 162:5, pages 1456-1475.e1.
Crossref
Crossref
Newton A C S Wong, Michael John Wallage, Paul Virgo & Hannah Lowes. (2022) Sampling endoscopically normal large bowel mucosa from patients presenting with elevated faecal calprotectin levels is not clinically justified. Journal of Clinical Pathology 75:3, pages 205-208.
Crossref
Crossref
Esther Bandala-Sanchez, Alexandra J. Roth-Schulze, Helena Oakey, Megan A.S. Penno, Naiara G. Bediaga, Gaetano Naselli, Katrina M. Ngui, Alannah D. Smith, Dexing Huang, Enrique Zozaya-Valdes, Rebecca L. Thomson, James D. Brown, Peter J. Vuillermin, Simon C. Barry, Maria E. Craig, William D. Rawlinson, Elizabeth A. Davis, Mark Harris, Georgia Soldatos, Peter G. Colman, John M. Wentworth, Aveni Haynes, Grant Morahan, Richard O. Sinnott, Anthony T. Papenfuss, Jennifer J. Couper & Leonard C. Harrison. (2022) Women with type 1 diabetes exhibit a progressive increase in gut Saccharomyces cerevisiae in pregnancy associated with evidence of gut inflammation. Diabetes Research and Clinical Practice 184, pages 109189.
Crossref
Crossref
Magne K. Fagerhol & Jarle Rugtveit. (2022) Heterogeneity of Fecal Calprotectin Reflecting Generation of Neutrophil Extracellular Traps (NETs) in the Gut: New Immunoassays Are Available. Journal of Molecular Pathology 3:1, pages 38-51.
Crossref
Crossref
Subarna Rani Das, A S M Bazlul Karim, Md RukonUzzaman, Md Wahiduzzaman Mazumder, Rubaiyat Alam, Md Benzamin, Parisa Marjan, Mst. Naznin Sarker, Hazera Akther & Mohuya Mondal. (2022) Juvenile Polyps in Bangladeshi Children and Their Association with Fecal Calprotectin as a Biomarker. Pediatric Gastroenterology, Hepatology & Nutrition 25:1, pages 52.
Crossref
Crossref
Wanli Xu, Yiming Zhang, Wenxiao Zhao, Jie Chen, Kendra Maas, Naveed Hussain, Wendy A. Henderson & Xiaomei Cong. (2022) Trends of fecal calprotectin levels and associations with early life experience in preterm infants. Interdisciplinary Nursing Research 1:1, pages 36-42.
Crossref
Crossref
Roberto Trasolini, Kai Zhu, Natasha Klemm, Sophia Park & Baljinder Salh. (2022) Fecal Leukocyte Esterase, an Alternative Biomarker to Fecal Calprotectin in Inflammatory Bowel Disease: A Pilot Series. Gastro Hep Advances 1:1, pages 45-51.
Crossref
Crossref
Roger Pero-Gascon, Lieselot Y. Hemeryck, Giulia Poma, Gwen Falony, Tim S. Nawrot, Jeroen Raes, Lynn Vanhaecke, Marthe De Boevre, Adrian Covaci & Sarah De Saeger. (2022) FLEXiGUT: Rationale for exposomics associations with chronic low-grade gut inflammation. Environment International 158, pages 106906.
Crossref
Crossref
Lisa Johnson. 2022.
129
153
.
Fabio Cherubini, Antonio Cristiano, Alessandra Valentini, Sergio Bernardini & Marzia Nuccetelli. (2021) Correction to: Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study. Inflammation Research 71:1, pages 1-8.
Crossref
Crossref
Shin Young Park, Sang Pyung Lee & Woo Jin Kim. (2021) Fecal Calprotectin Is Increased in Stroke. Journal of Clinical Medicine 11:1, pages 159.
Crossref
Crossref
Reza Shirazinia, Ali Akbar Golabchifar & Mohammad Reza Fazeli. (2021) Efficacy of probiotics for managing infantile colic due to their anti-inflammatory properties: a meta-analysis and systematic review. Clinical and Experimental Pediatrics 64:12, pages 642-651.
Crossref
Crossref
Liyan Qiu, Junli Wang, Fang Ren, Lixiao Shen & Feng Li. (2021) Can fecal calprotectin levels be used to monitor infant milk protein allergies?. Allergy, Asthma & Clinical Immunology 17:1.
Crossref
Crossref
Natalia Kozlyuk, Benjamin A. Gilston, Lauren E. Salay, Rocco D. Gogliotti, Plamen P. Christov, Kwangho Kim, Mohiuddin Ovee, Alex G. Waterson & Walter J. Chazin. (2021)
A
fragment‐based
approach to discovery of Receptor for Advanced Glycation End products inhibitors
. Proteins: Structure, Function, and Bioinformatics 89:11, pages 1399-1412.
Crossref
Crossref
Almina Jukic, Latifa Bakiri, Erwin F. Wagner, Herbert Tilg & Timon E. Adolph. (2021) Calprotectin: from biomarker to biological function. Gut 70:10, pages 1978-1988.
Crossref
Crossref
Nikolas Plevris, James Fulforth, Mathew Lyons, Spyros I. Siakavellas, Philip W. Jenkinson, Cher S. Chuah, Laura Lucaciu, Rebecca J. Pattenden, Ian D. Arnott, Gareth-Rhys Jones & Charlie W. Lees. (2021) Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology 19:9, pages 1835-1844.e6.
Crossref
Crossref
Jéssica A. Barbosa, Lucas A. Rodrigues, Daniel A. Columbus, Juan C. P. Aguirre, John C. S. Harding, Vinícius S. Cantarelli & Matheus de O. Costa. (2021) Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis. Porcine Health Management 7:1.
Crossref
Crossref
Fang Chen, Yue Hu, Yi-Hong Fan & Bin Lv. (2021) Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis. Frontiers in Medicine 8.
Crossref
Crossref
Mauro Giuffrè, Luigi Vetrugno, Stefano Di Bella, Rita Moretti, Debora Berretti & Lory Saveria Crocè. (2021) Calprotectin and SARS-CoV-2: A Brief-Report of the Current Literature. Healthcare 9:8, pages 956.
Crossref
Crossref
Colleen E. Shelly, Evgenia J. Filatava, Julie Thai, Britt F. Pados, Sara E. Rostas, Hidemi Yamamoto, Raina Fichorova & Katherine E. Gregory. (2021) Elevated Intestinal Inflammation in Preterm Infants With Signs and Symptoms of Gastroesophageal Reflux Disease. Biological Research For Nursing 23:3, pages 524-532.
Crossref
Crossref
Fabio Cherubini, Antonio Cristiano, Alessandra Valentini, Sergio Bernardini & Marzia Nuccetelli. (2021) Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study. Inflammation Research 70:6, pages 687-694.
Crossref
Crossref
Yee Man Kan, Sin Yan Chu & Ching Kong Loo. (2021) Diagnostic accuracy of fecal calprotectin in predicting significant gastrointestinal diseases. JGH Open 5:6, pages 647-652.
Crossref
Crossref
Gabriela C. Dal Pont, Bruna L. Belote, Annah Lee, Cristiano Bortoluzzi, Cinthia Eyng, Milena Sevastiyanova, Alireza Khadem, Elizabeth Santin, Yuhua Z. Farnell, Christos Gougoulias & Michael H. Kogut. (2021) Novel Models for Chronic Intestinal Inflammation in Chickens: Intestinal Inflammation Pattern and Biomarkers. Frontiers in Immunology 12.
Crossref
Crossref
M.S. Ismail, Serhiy Semenov & Deirdre McNamara. (2021) The utility of faecal and urine biomarkers for small bowel diseases. Current Opinion in Gastroenterology 37:3, pages 284-294.
Crossref
Crossref
Ferdinando D'Amico, David T. Rubin, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Taku Kobayashi, Pablo A. Olivera, Peter Bossuyt, Lieven Pouillon, Edouard Louis, Eugeni Domènech, Subrata Ghosh, Silvio Danese & Laurent Peyrin‐Biroulet. (2021) International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases. United European Gastroenterology Journal 9:4, pages 451-460.
Crossref
Crossref
Carmen Ribes Koninckx, Ester Donat, Marc A. Benninga, Ilse J. Broekaert, Frederic Gottrand, Kaija-Leena Kolho, Paolo Lionetti, Erasmo Miele, Rok Orel, Alexandra Papadopoulou, Corina Pienar, Michela G. Schäppi, Michael Wilschanski & Nikhil Thapar. (2021) The Use of Fecal Calprotectin Testing in Paediatric Disorders: A Position Paper of the European Society for Paediatric Gastroenterology and Nutrition Gastroenterology Committee. Journal of Pediatric Gastroenterology & Nutrition 72:4, pages 617-640.
Crossref
Crossref
Shane O’Driscoll, Carolyn Piggott, Helen Bruce & Sally C. Benton. (2021) An evaluation of ten external quality assurance scheme (EQAS) materials for the faecal immunochemical test (FIT) for haemoglobin. Clinical Chemistry and Laboratory Medicine (CCLM) 59:2, pages 307-313.
Crossref
Crossref
Ourania S. Kotsiou, Dimitrios Papagiannis, Rodanthi Papadopoulou & Konstantinos I. Gourgoulianis. (2021) Calprotectin in Lung Diseases. International Journal of Molecular Sciences 22:4, pages 1706.
Crossref
Crossref
Allison Ross Eckard, Heather Y. Hughes, Nancy L. Hagood, Mary Ann O'Riordan, Danielle Labbato, Julia C. Kosco, Sarah E. Scott & Grace A. McComsey. (2021) Fecal Calprotectin Is Elevated in HIV and Related to Systemic Inflammation. JAIDS Journal of Acquired Immune Deficiency Syndromes 86:2, pages 231-239.
Crossref
Crossref
Chandni Patel, Ladina Keller, Sophie Welsche, Jan Hattendorf, Somphou Sayasone, Said M. Ali, Shaali M. Ame, Jean Tenena Coulibaly, Eveline Hürlimann & Jennifer Keiser. (2021) Assessment of fecal calprotectin and fecal occult blood as point-of-care markers for soil-transmitted helminth attributable intestinal morbidity in a case-control substudy conducted in Côte d'Ivoire, Lao PDR and Pemba Island, Tanzania. EClinicalMedicine 32, pages 100724.
Crossref
Crossref
Emiko Mizoguchi, Renuka Subramaniam, Toshiyuki Okada & Atsushi Mizoguchi. (2021) A Review of Selected IBD Biomarkers: From Animal Models to Bedside. Diagnostics 11:2, pages 207.
Crossref
Crossref
Xiaoqi Ye, Ying Wang, Harry H. X. Wang, Rui Feng, Ziyin Ye, Jing Han, Li Li, Zhirong Zeng, Minhu Chen & Shenghong Zhang. (2021) Can fecal calprotectin accurately identify histological activity of ulcerative colitis? A meta-analysis. Therapeutic Advances in Gastroenterology 14, pages 175628482199474.
Crossref
Crossref
Ludimilla dos Reis Malvão, Kalil Madi, Barbara Cathalá Esberard, Renata Fernandes de Amorim, Kelly dos Santos Silva, Katia Farias e Silva, Heitor Siffert Pereira de Souza & Ana Teresa Pugas Carvalho. (2021) Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis. Medicine 100:3, pages e24058.
Crossref
Crossref
Hui Shi, Yu Zuo, Srilakshmi Yalavarthi, Kelsey Gockman, Melanie Zuo, Jacqueline A Madison, Christopher Blair, Wrenn Woodward, Sean P Lezak, Njira L Lugogo, Robert J Woods, Christian Lood, Jason S Knight & Yogendra Kanthi. (2021) Neutrophil calprotectin identifies severe pulmonary disease in COVID-19. Journal of Leukocyte Biology 109:1, pages 67-72.
Crossref
Crossref
Rayna Shentova-Eneva & Tsvetelina Velikova. (2020) Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What’s New?. Gastroenterology Insights 11:2, pages 58-71.
Crossref
Crossref
Harshit DoshiShachee PandyaChampa N. CodipillyRichard J. Schanler. (2020) Does Human Milk Fortifier Affect Intestinal Inflammation in Preterm Infants?. Breastfeeding Medicine 15:12, pages 776-778.
Crossref
Crossref
María Roca, Ana Rodriguez Varela, Eva Carvajal, Ester Donat, Francisco Cano, Ana Armisen, Maria Jose Vaya, Helena Ekoff, David Hervas, Niclas Rydell & Carmen Ribes-Koninckx. (2020) Fecal calprotectin in healthy children aged 4–16 years. Scientific Reports 10:1.
Crossref
Crossref
Lena Jafri, Ayra Siddiqui, Sabeeh Sidddique, Om Parkash, Rizwana Kausar & Hafsa Majid. (2020) Clinical Spectrum in a Cohort of Patients With High Fecal Calprotectin Levels. Cureus.
Crossref
Crossref
Fatemeh Khaki-Khatibi, Durdi Qujeq, Mehrdad Kashifard, Soheila Moein, Mahmood Maniati & Mostafa Vaghari-Tabari. (2020) Calprotectin in inflammatory bowel disease. Clinica Chimica Acta 510, pages 556-565.
Crossref
Crossref
Wenqing Zhou, Huiying Qiao, Weiguo Yuan, Zhibing Yao, Kai Liu, Jun Wang & Yongkui Pang. (2020) Diagnostic utility of fecal calprotectin in patients presenting to the emergency department with suspected acute appendicitis. The American Journal of Emergency Medicine 38:11, pages 2303-2307.
Crossref
Crossref
Sjoukje-Marije Haisma, Patrick Ferry van Rheenen, Lucie Wagenmakers & Anneke Muller Kobold. (2020) Calprotectin instability may lead to undertreatment in children with IBD. Archives of Disease in Childhood 105:10, pages 996-998.
Crossref
Crossref
TETSUSHI KINUGASA, KEIICHI MITSUYAMA, KENTA MUROTANI, TOMOAKI MIZOBE, TAKAFUMI OCHI, TETSUHIRO YOSHIMURA, KOUTAROU KUWAKI, TARO ISOBE & YOSHITO AKAGI. (2020) Non-invasive Monitoring of Pouchitis After Total Proctocolectomy Using Fecal Calprotectin Levels. The Kurume Medical Journal 67:2.3, pages 57-63.
Crossref
Crossref
Shin Young Park. (2020) Age-Related Fecal Calprotectin Concentrations in Healthy Adults. The Korean Journal of Clinical Laboratory Science 52:3, pages 181-187.
Crossref
Crossref
Christian Maaser, Frauke Petersen, Ulf Helwig, Imma Fischer, Alexander Roessler, Stefan Rath, Dorothee Lang & Torsten Kucharzik. (2020) Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study. Gut 69:9, pages 1629-1636.
Crossref
Crossref
Beata Polkowska-Pruszyńska, Agnieszka Gerkowicz, Karol Rawicz-Pruszyński & Dorota Krasowska. (2020) The Role of Fecal Calprotectin in Patients with Systemic Sclerosis and Small Intestinal Bacterial Overgrowth (SIBO). Diagnostics 10:8, pages 587.
Crossref
Crossref
R. Vicente-Steijn, J.M. Jansen, R. Bisheshar & I.-A. Haagen. (2020) Analytical and clinical performance of the fully-automated LIAISONXL calprotectin immunoassay from DiaSorin in IBD patients. Practical Laboratory Medicine 21, pages e00175.
Crossref
Crossref
Samira Charkhizadeh, Mehdi Imani, Nematollah Gheibi, Fateme Shabaani, Akbar Nikpajouh & Mohammad R. Rezvany. (2020) In Vitro Inhibitory Effect of Recombinant Human Calprotectin on Nalm6 Leukemia Cell Line. Anti-Cancer Agents in Medicinal Chemistry 20:8, pages 951-962.
Crossref
Crossref
Jost Langhorst, Lana Kairey, Angela Oberle, James Boone, Gustav Dobos, Hendrik Juette, Andrea Tannapfel & Andreas Rueffer. (2020) Assessing Histological Inflammatory Activity in Patients With Ulcerative Colitis: A Diagnostic Accuracy Study Testing Fecal Biomarkers Lactoferrin and Calprotectin. Crohn's & Colitis 360 2:3.
Crossref
Crossref
Natália Sousa Freitas Queiroz, Takayuki Yamamoto & Paulo Gustavo Kotze. (2020) Optimal strategies to prevent recrudescent Crohn's disease after resection. Seminars in Colon and Rectal Surgery 31:2, pages 100746.
Crossref
Crossref
Makoto Naganuma, Taku Kobayashi, Masanao Nasuno, Satoshi Motoya, Shingo Kato, Katsuyoshi Matsuoka, Ryota Hokari, Chikako Watanabe, Hirotsugu Sakamoto, Hironori Yamamoto, Makoto Sasaki, Kenji Watanabe, Hideki Iijima, Yutaka Endo, Hitoshi Ichikawa, Keiji Ozeki, Satoshi Tanida, Nobuhiro Ueno, Mikihiro Fujiya, Minako Sako, Ken Takeuchi, Shinya Sugimoto, Takayuki Abe, Toshifumi Hibi, Yasuo Suzuki & Takanori Kanai. (2020) Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative Colitis. Clinical Gastroenterology and Hepatology 18:5, pages 1102-1111.e5.
Crossref
Crossref
Toshio Watanabe, Yasuhiro Fujiwara & Francis K. L. Chan. (2019) Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review. Journal of Gastroenterology 55:5, pages 481-495.
Crossref
Crossref
Judith Zeevenhooven, Robyn Rexwinkel, Ellen Tromp, Bart Haver, Michael Groeneweg, Marc A. Benninga & Arine M. Vlieger. (2020) Clinical Evaluation of Inflammatory and Blood Parameters in the Workup of Pediatric Chronic Abdominal Pain. The Journal of Pediatrics 219, pages 76-82.e3.
Crossref
Crossref
Beata Łoniewska, Karolina Adamek, Dagmara Węgrzyn, Mariusz Kaczmarczyk, Karolina Skonieczna-Żydecka, Jeremy Clark, Grażyna Adler, Joanna Tousty, Izabela Uzar, Piotr Tousty & Igor Łoniewski. (2020) Analysis of Faecal Zonulin and Calprotectin Concentrations in Healthy Children During the First Two Years of Life. An Observational Prospective Cohort Study. Journal of Clinical Medicine 9:3, pages 777.
Crossref
Crossref
Jeanette Manoppo, Rizal Somali & PITIKA ASPR. (2020) Fecal calprotectin and its association with functional dyspepsia in children. Paediatrica Indonesiana 60:2, pages 72-6.
Crossref
Crossref
Christopher J Black & Alexander C Ford. (2020) Rational investigations in irritable bowel syndrome. Frontline Gastroenterology 11:2, pages 140-147.
Crossref
Crossref
Laura Francesca Pisani, Manuela Moriggi, Cecilia Gelfi, Maurizio Vecchi & Luca Pastorelli. (2020) Proteomic insights on the metabolism in inflammatory bowel disease. World Journal of Gastroenterology 26:7, pages 696-705.
Crossref
Crossref
Patrick M. Bossuyt, Maria Olsen, Chris Hyde & Jérémie F. Cohen. (2020) An analysis reveals differences between pragmatic and explanatory diagnostic accuracy studies. Journal of Clinical Epidemiology 117, pages 29-35.
Crossref
Crossref
Corinne Chmiel, Oliver Senn, Susann Hasler, Thomas Rosemann, Gerhard Rogler, Nadine Zahnd, Ryan Tandjung, Nathalie Scherz, Michael Christian Sulz & Stephan Vavricka. (2019) Can the CalproQuest predict a positive Calprotectin test? A prospective diagnostic study. PLOS ONE 14:11, pages e0224961.
Crossref
Crossref
Joseph Amara, Youakim Saliba, Joelle Hajal, Viviane Smayra, Jules-Joel Bakhos, Raymond Sayegh & Nassim Fares. (2019) Circadian Rhythm Disruption Aggravates DSS-Induced Colitis in Mice with Fecal Calprotectin as a Marker of Colitis Severity. Digestive Diseases and Sciences 64:11, pages 3122-3133.
Crossref
Crossref
Anneline Cremer, Jade Ku, Leila Amininejad, Marie-Rose Bouvry, Fabian Brohet, Claire Liefferinckx, Jacques Devière, André van Gossum, Julie Smet, Patrick Stordeur & Denis Franchimont. (2019) Variability of Faecal Calprotectin in Inflammatory Bowel Disease Patients: An Observational Case-control Study. Journal of Crohn's and Colitis 13:11, pages 1372-1379.
Crossref
Crossref
Jeffrey A Berinstein, Calen A Steiner, Athos Bousvaros, Felix P Tiongco, Eugene Greenberg, Robert Hardi, Anthony J Lembo, Keith Friedenberg, Shahriar Sedghi, Alison Fint, David A Florez, Ashutosh Kumar, Razvan Arsenescu, K T Park, Peter Kupchak, Alanna Grob, James Leavitt & Peter D R Higgins. (2019) The Clinical Accuracy of the BÜHLMANN fCAL ELISA in the Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome: A Multicenter Prospective Case–Control Study. Crohn's & Colitis 360 1:3.
Crossref
Crossref
Claire Wang, Hannah M. Baer, Daniel R. Gaya, Robert J.B. Nibbs & Simon Milling. (2019) Can molecular stratification improve the treatment of inflammatory bowel disease?. Pharmacological Research 148, pages 104442.
Crossref
Crossref
Nicholas A. Kennedy, Gareth-Rhys Jones, Nikolas Plevris, Rebecca Patenden, Ian D. Arnott & Charlie W. Lees. (2019) Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease. Clinical Gastroenterology and Hepatology 17:11, pages 2269-2276.e4.
Crossref
Crossref
Su Jin Jeong. (2019) The role of fecal calprotectin in pediatric disease. Korean Journal of Pediatrics 62:8, pages 287-291.
Crossref
Crossref
Martijn Ramon Brands, Els Van de Vijver, Sjoukje Marije Haisma, Anke Heida & Patrick Ferry van Rheenen. (2019)
No association between abdominal pain and
Dientamoeba
in Dutch and Belgian children
. Archives of Disease in Childhood 104:7, pages 686-689.
Crossref
Crossref
Tereza Lerchova, Ondrej Hradsky, Ivana Copova, Kristyna Potuznikova, Lucie Gonsorcikova & Jiri Bronsky. (2019) The Accuracy of a Home-performed Faecal Calprotectin Test in Paediatric Patients With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 69:1, pages 75-81.
Crossref
Crossref
Adi Lahat, Daniela Necula, Miri Yavzori, Orit Picard, Sharon Halperin, Rami Eliakim & Shomron Ben-Horin. (2019) Prolonged Recurrent Abdominal Pain is Associated With Ongoing Underlying Mucosal Inflammation in Patients who had an Episode of Acute Complicated Diverticulitis. Journal of Clinical Gastroenterology 53:5, pages e178-e185.
Crossref
Crossref
Beata Łoniewska, Dagmara Węgrzyn, Karolina Adamek, Mariusz Kaczmarczyk, Karolina Skonieczna-Żydecka, Grażyna Adler, Agata Jankowska, Izabela Uzar, Agnieszka Kordek, Marta Celewicz & Igor Łoniewski. (2019) The Influence of Maternal-Foetal Parameters on Concentrations of Zonulin and Calprotectin in the Blood and Stool of Healthy Newborns during the First Seven Days of Life. An Observational Prospective Cohort Study. Journal of Clinical Medicine 8:4, pages 473.
Crossref
Crossref
Jonathan T Avila, KT Park & Neville H Golden. (2019) Eating disorders in adolescents with chronic gastrointestinal and endocrine diseases. The Lancet Child & Adolescent Health 3:3, pages 181-189.
Crossref
Crossref
Gordana Juricic, Tina Brencic, Andrea Tesija Kuna, Milena Njegovan & Lorena Honovic. (2019) Faecal calprotectin determination: impact of preanalytical sample treatment and stool consistency on within- and between-method variability. Biochemia medica 29:1, pages 112-122.
Crossref
Crossref
Jae Myung Cha. (2019) Fecal calprotectin in daily practice for patients with inflammatory bowel disease: where do we
stand in Korea?. The Korean Journal of Internal Medicine 34:1, pages 60-62.
Crossref
Crossref
Aryamitra Banerjee & Ramesh C. Gupta. 2019. Biomarkers in Toxicology. Biomarkers in Toxicology
277
285
.
Udayakumar Navaneethan. 2019. Pouchitis and Ileal Pouch Disorders. Pouchitis and Ileal Pouch Disorders
237
246
.
Kurvi Patwala & Peter De Cruz. 2019. Biomarkers in Inflammatory Bowel Diseases. Biomarkers in Inflammatory Bowel Diseases
89
97
.
Takahiro Shimoyama, Takayuki Yamamoto, Satoru Umegae & Koichi Matsumoto. (2018) Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study. BMC Gastroenterology 18:1.
Crossref
Crossref
Fumihiko Iwamoto, Katsuyoshi Matsuoka, Maiko Motobayashi, Kento Takenaka, Toru Kuno, Keisuke Tanaka, Yuya Tsukui, Shoji Kobayashi, Takashi Yoshida, Toshimitsu Fujii, Eiko Saito, Tatsuya Yamaguchi, Masakazu Nagahori, Tadashi Sato, Kazuo Ohtsuka, Nobuyuki Enomoto & Mamoru Watanabe. (2018) Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon‐assisted endoscopy. Journal of Gastroenterology and Hepatology 33:12, pages 1984-1989.
Crossref
Crossref
Hayandra Ferreira Nanini, Claudio Bernardazzi, Fernando Castro & Heitor Siffert Pereira de Souza. (2018) Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets. World Journal of Gastroenterology 24:41, pages 4622-4634.
Crossref
Crossref
Dong Ju Kim, Yoon Mi Jeoun, Dong-won Lee, Ja Seol Koo & Sang Woo Lee. (2018) Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis. Intestinal Research 16:4, pages 563-570.
Crossref
Crossref
Andrea Padoan, Renata D’Incà, Maria Luisa Scapellato, Rudi De Bastiani, Roberta Caccaro, Claudia Mescoli, Stefania Moz, Dania Bozzato, Carlo-Federico Zambon, Greta Lorenzon, Massimo Rugge, Mario Plebani & Daniela Basso. (2018) Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability. Clinical Chemistry and Laboratory Medicine (CCLM) 56:11, pages 1926-1935.
Crossref
Crossref
Catherine Reenaers, Peter Bossuyt, Pieter Hindryckx, Hilde Vanpoucke, Anneline Cremer & Filip Baert. (2018) Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice. United European Gastroenterology Journal 6:8, pages 1117-1125.
Crossref
Crossref
Jordi Guardiola, Triana Lobatón, Elena Cerrillo, Rocío Ferreiro-Iglesias, Javier P. Gisbert, Eugeni Domènech, María Chaparro, Maria Esteve & Francisco Rodríguez-Moranta. (2018) Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre la utilidad de la determinación de calprotectina fecal en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 41:8, pages 514-529.
Crossref
Crossref
Jordi Guardiola, Triana Lobatón, Elena Cerrillo, Rocío Ferreiro-Iglesias, Javier P. Gisbert, Eugeni Domènech, María Chaparro, Maria Esteve & Francisco Rodríguez-Moranta. (2018) Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel disease. Gastroenterología y Hepatología (English Edition) 41:8, pages 514-529.
Crossref
Crossref
Maria Gloria Mumolo, Lorenzo Bertani, Linda Ceccarelli, Gabriella Laino, Giorgia Di Fluri, Eleonora Albano, Gherardo Tapete & Francesco Costa. (2018) From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World Journal of Gastroenterology 24:33, pages 3681-3694.
Crossref
Crossref
Eun Soo Kim. (2018) Optimal Usage of Fecal Calprotectin for Intestinal Diseases. The Korean Journal of Medicine 93:4, pages 364-368.
Crossref
Crossref
Stephan R Vavricka, Henriette Heinrich, Simon Buetikofer, Flavia Breitenmoser, Emanuel Burri, Xiaoye Schneider-Yin, Jasmin Barman-Aksoezen, Luc Biedermann, Michael Scharl, Jonas Zeitz, Gerhard Rogler, Benjamin Misselwitz & Matthias Sauter. (2018) The Vampire Study: Significant elevation of faecal calprotectin in healthy volunteers after 300 ml blood ingestion mimicking upper gastrointestinal bleeding. United European Gastroenterology Journal 6:7, pages 1007-1014.
Crossref
Crossref
Y. B. Uspenskaya & S. J. Belogubova. (2018) DIAGNOSTIC POSSIBILITIES OF FECAL CALPROTECTIN APPLICATION IN PATIENTS WITH INFLAMMATORY DOWEL DISEASES DURING PREGNANCY (literature review and clinical observations). Koloproktologia:2, pages 95-101.
Crossref
Crossref
Tom Nilsen, Siri Helen Haugen & Anders Larsson. (2018)
Extraction, isolation, and concentration of calprotectin antigen (
S100A8/S100A9
) from granulocytes
. Health Science Reports 1:5.
Crossref
Crossref
Vanesa Jusué, María Chaparro & Javier P. Gisbert. (2018) Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease. Digestive and Liver Disease 50:4, pages 353-359.
Crossref
Crossref
Gea Holtman. (2018) Calprotectinetest kan inflammatoire darmziekte veilig uitsluiten. Huisarts en wetenschap 61:4, pages 29-33.
Crossref
Crossref
Rocio Ferreiro-Iglesias, Manuel Barreiro-de Acosta, Aurelio Lorenzo-Gonzalez & Juan E. Dominguez-Muñoz. (2018) Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance With Anti-TNF Therapy. Journal of Clinical Gastroenterology 52:3, pages 229-234.
Crossref
Crossref
F. Di Berardino, D. Zanetti, E. Ciusani, C. Caccia, V. Leoni, U. De Grazia, E. Filipponi & L. Elli. (2018) Intestinal permeability and Ménière's disease. American Journal of Otolaryngology 39:2, pages 153-156.
Crossref
Crossref
Börje Jonefjäll, Magnus Simrén, Anders Lasson, Lena Öhman & Hans Strid. (2017) Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis. United European Gastroenterology Journal 6:1, pages 148-158.
Crossref
Crossref
Young-Eun Kim, Minji Lee, Hyejung Gu, Jeongwoo Kim, Seongju Jeong, Sujin Yeo, You Jeong Lee, Sin-Hyeog Im, Young-Chul Sung, Hak Jae Kim, Irving L. Weissman & G-One Ahn. (2018) Hypoxia-inducible factor-1 (HIF-1) activation in myeloid cells accelerates DSS-induced colitis progression in mice. Disease Models & Mechanisms.
Crossref
Crossref
Yuen Sau Tham, Diana E. Yung, Shmuel Fay, Takayuki Yamamoto, Shomron Ben-Horin, Rami Eliakim, Anastasios Koulaouzidis & Uri Kopylov. (2018) Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 11, pages 175628481878557.
Crossref
Crossref
Ruth M. Ayling & Klaartje Kok. 2018.
161
190
.
Ivy K.M. Law, Michelle W. Cheng, David Q. Shih, Dermot P.B. McGovern & Hon Wai Koon. 2018. Antimicrobial Peptides in Gastrointestinal Diseases. Antimicrobial Peptides in Gastrointestinal Diseases
35
60
.
Amy K. Schaefer, James E. Melnyk, Zhaoping He, Fernando Del Rosario & Catherine L. Grimes. 2018. Immunity and Inflammation in Health and Disease. Immunity and Inflammation in Health and Disease
175
187
.
Maria Karolina Jonsson, Nina Paulshus Sundlisæter, Hilde Haugedal Nordal, Hilde Berner Hammer, Anna-Birgitte Aga, Inge Christoffer Olsen, Karl Albert Brokstad, Désirée van der Heijde, Tore K Kvien, Bjørg-Tilde Svanes Fevang, Siri Lillegraven & Espen A Haavardsholm. (2017) Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis. Annals of the Rheumatic Diseases 76:12, pages 2031-2037.
Crossref
Crossref
Victoria Harris & Saxon D Smith. (2017) Chronic cheilitis: Faecal calprotectin test a way to diagnose oral Crohn's disease. Australasian Journal of Dermatology 58:4, pages 324-325.
Crossref
Crossref
Katrine Carlsen, Christian Jakobsen, Thomas Kallemose, Anders Paerregaard, Lene B. Riis, Pia MunkholmVibeke Wewer. (2017) F-calprotectin and Blood Markers Correlate to Quality of Life in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 65:5, pages 539-545.
Crossref
Crossref
Britta Noebauer, Lejla Ramic, Andrea Konstantin, Christina Zachbauer & Elisa Einwallner. (2017) Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting. Biochemia Medica 27:3.
Crossref
Crossref
Joachim Høg Mortensen, Tina Manon-Jensen, Michael Dam Jensen, Per Hägglund, Lone Gabriels Klinge, Jens Kjeldsen, Aleksander Krag, Morten Asser Karsdal & Anne-Christine Bay-Jensen. (2017) Ulcerative colitis, Crohn’s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn’s disease. PLOS ONE 12:10, pages e0185855.
Crossref
Crossref
E. Klang, U. Kopylov, R. Eliakim, N. Rozendorn, D. Yablecovitch, A. Lahat, S. Ben-Horin & M.M. Amitai. (2017) Diffusion-weighted imaging in quiescent Crohn's disease: correlation with inflammatory biomarkers and video capsule endoscopy. Clinical Radiology 72:9, pages 798.e7-798.e13.
Crossref
Crossref
Chloé Maréchal, Isabelle Aimone‐Gastin, Cédric Baumann, Bastien Dirrenberger, Jean‐Louis Guéant & Laurent Peyrin‐Biroulet. (2017) Compliance with the faecal calprotectin test in patients with inflammatory bowel disease. United European Gastroenterology Journal 5:5, pages 702-707.
Crossref
Crossref
Rikke Asmussen Andreasen, Lars Erik Kristensen, Torkell Ellingsen, Robin Christensen, Xenofon Baraliakos, Jimmi Wied, Claus Aalykke, Thomas Ulstrup, Berit Schiøttz-Christensen, Hans Christian Horn, Amir Emamifar, Bent Duerlund, Lars Fischer & Inger Marie Jensen Hansen. (2017) Clinical characteristics of importance to outcome in patients with axial spondyloarthritis: protocol for a prospective descriptive and exploratory cohort study. BMJ Open 7:7, pages e015536.
Crossref
Crossref
Anke Heida, K. T. Park & Patrick F. van Rheenen. (2017) Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 23:6, pages 894-902.
Crossref
Crossref
Yu Fu, Lingli Wang, Cheng Xie, Kaifang Zou, Lei Tu, Wei Yan & Xiaohua Hou. (2017) Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation. Scientific Reports 7:1.
Crossref
Crossref
Rebecca K McCann, Karen Smith & Daniel R Gaya. (2017) A prospective single centre pilot evaluation of a serum calprotectin assay in unselected GI patients. Clinical Biochemistry 50:9, pages 533-536.
Crossref
Crossref
Elisabetta Metafuni, Sabrina Giammarco, Daniela Giovanna De Ritis, Monica Rossi, Teresa De Michele, Cecilia Zuppi, Andrea P. Bacigalupo, Simona Sica & Patrizia Chiusolo. (2017) Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. Annals of Hematology 96:6, pages 929-933.
Crossref
Crossref
Yoo Mi Lee, Chae-Yeon Min, You Jin Choi & Su Jin Jeong. (2017) Delivery and feeding mode affects fecal calprotectin levels in infants < 7 months old. Early Human Development 108, pages 45-48.
Crossref
Crossref
Stephanie Van Biervliet, Dimitri Declercq & Shawn Somerset. (2017) Clinical effects of probiotics in cystic fibrosis patients: A systematic review. Clinical Nutrition ESPEN 18, pages 37-43.
Crossref
Crossref
Maria Rosaria Iovene, Francesca Bombace, Roberta Maresca, Anna Sapone, Patrizia Iardino, Annarita Picardi, Rosa Marotta, Chiara Schiraldi, Dario Siniscalco, Nicola Serra, Laura de Magistris & Carmela Bravaccio. (2016) Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders. Mycopathologia 182:3-4, pages 349-363.
Crossref
Crossref
Robert N Lopez, Steven T Leach, Daniel A Lemberg, Gilles Duvoisin, Richard B Gearry & Andrew S Day. (2017) Fecal biomarkers in inflammatory bowel disease. Journal of Gastroenterology and Hepatology 32:3, pages 577-582.
Crossref
Crossref
Duk Hwan Kim, Yehyun Park, Bun Kim, Seung Won Kim, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim & Jae Hee Cheon. (2017) Fecal calprotectin as a non-invasive biomarker for intestinal involvement of Behçet's disease. Journal of Gastroenterology and Hepatology 32:3, pages 595-601.
Crossref
Crossref
Stanisław Pieczarkowski, Kinga Kowalska-Duplaga, Andrzej Wędrychowicz, Krzysztof Fyderek, Przemko Kwinta, Agnieszka Radom, Andrzej Zając & Przemysław Tomasik. (2017) Calprotectin (S100 A8/A9) and TNF-alpha in differential diagnosis of chronic abdominal pain in children. Diagnostyka Laboratoryjna 53:1, pages 5-10.
Crossref
Crossref
Katrine Carlsen, Christian Jakobsen, Gunnar Houen, Thomas Kallemose, Anders Paerregaard, Lene B. Riis, Pia Munkholm & Vibeke Wewer. (2017) Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease. Inflammatory Bowel Diseases, pages 1.
Crossref
Crossref
Maxime M.W. De Sloovere, Dieter De Smet, Filip J. Baert, Johan Debrabandere & Hilde J.M. Vanpoucke. (2017) Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease. Clinical Chemistry and Laboratory Medicine (CCLM) 55:9.
Crossref
Crossref
Yoshiharu Yamaguchi, Hisatsugu Noda, Noriko Okaniwa, Kazunori Adachi, Tetsuya Shinmura, Shoko Nakagawa, Masahide Ebi, Naotaka Ogasawara, Yasushi Funaki, Lisheng Zhuo, Koji Kimata, Makoto Sasaki & Kunio Kasugai. (2017) Serum-Derived Hyaluronan-Associated Protein Is a Novel Biomarker for Inflammatory Bowel Diseases. Digestion 95:2, pages 146-155.
Crossref
Crossref
Saranya Kittanakom, Md. Sharif Shajib, Kristine Garvie, Joceline Turner, Dan Brooks, Sufian Odeh, Robert Issenman, V. Tony Chetty, Joseph Macri & Waliul I. Khan. (2017) Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology 2017, pages 1-10.
Crossref
Crossref
Displaying 200 of 465 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list